Inactive

The following amendment 2 is for the following reasons: Extent the response date till 8/29/2024 at 10:00 am ET, to add option periods to the Request for Quote. All other terms and conditions remain un... The following amendment 2 is for the following reasons: Extent the response date till 8/29/2024 at 10:00 am ET, to add option periods to the Request for Quote. All other terms and conditions remain unchanged. *************************************************************************************** This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 as supplemented with FAR 13 and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE SOLICITATION WILL NOT BE ISSUED. The solicitation number for this acquisition is 75F40124Q00381 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 334516 and Full and Open Competition. This will be awarded as Firm-Fixed Price. Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.gov. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary. The Government intends to issue a Purchase Order. The U.S. Food and Drug Administration (FDA) has a need to Lease Oxford Nanopore PromethION 2 Solo long read sequencing instrument and purchase of consumables. See the Attachment for the AMENDMENT 2 RFQ 75F40124Q00318 in full text.